At a glance
- Originator Unknown
- Developer Wyeth
- Class Cardiotonics; Pyrimidines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 23 Jan 2001 Discontinued - Phase-II for Heart failure in USA (unspecified route)